ALAN SWANN to Placebos
This is a "connection" page, showing publications ALAN SWANN has written about Placebos.
Connection Strength
0.258
-
Psychosis in mania: specificity of its role in severity and treatment response. J Clin Psychiatry. 2004 Jun; 65(6):825-9.
Score: 0.051
-
Low dose zolmitriptan as a 5-HT neuroendocrine challenge agent in humans. Psychoneuroendocrinology. 2000 Aug; 25(6):607-18.
Score: 0.039
-
Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. Am J Psychiatry. 1999 Aug; 156(8):1264-6.
Score: 0.036
-
Depression during mania. Treatment response to lithium or divalproex. Arch Gen Psychiatry. 1997 Jan; 54(1):37-42.
Score: 0.031
-
Zolmitriptan and human aggression: interaction with alcohol. Psychopharmacology (Berl). 2010 Jul; 210(4):521-31.
Score: 0.019
-
A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania. J Clin Psychiatry. 2006 Oct; 67(10):1501-10.
Score: 0.015
-
Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder. Am J Psychiatry. 2005 Mar; 162(3):621-4.
Score: 0.013
-
A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome. J Clin Psychiatry. 2004 Jan; 65(1):114-9.
Score: 0.012
-
A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry. 2000 Nov; 61(11):841-50.
Score: 0.010
-
A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry. 2000 May; 57(5):481-9.
Score: 0.010
-
Maintenance clinical trials in bipolar disorder: design implications of the divalproex-lithium-placebo study. Psychopharmacol Bull. 1997; 33(4):693-9.
Score: 0.008
-
Relation of serum valproate concentration to response in mania. Am J Psychiatry. 1996 Jun; 153(6):765-70.
Score: 0.007
-
Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA. 1994 Mar 23-30; 271(12):918-24.
Score: 0.006